Although the U.S. Food and Drug Administration has received more than 10,000 complaints and 30,00 adverse event reports connected to the permanent birth control device Essure since its approval in 2002, only a little over 1,000 lawsuits have been filed.
The relatively small number of Essure lawsuits brought may be due to a legal doctrine known as preemption, which basically means that federal law trumps local law.
Since Essure was approved by a federal agency through the FDA’s 510(k) Pre-Approval Process, Bayer (the manufacturer of Essure) cannot easily be held liable for violations of state and local consumer protection laws.
To overcome the doctrine of preemption that is currently protecting Bayer from liability, injured parties will have to prove that the company was negligent in violation of federal law.
Unfortunately, it often doesn’t matter how negligent the company is, as long as there has been no violation of federal law.
Preemption has been an issue for the Essure lawsuits, but the tide may be turning for Essure plaintiffs.
Earlier this month, a state judge in California granted a motion allowing 55 of these lawsuits to be coordinated and assigned to one court.
This move could allow Essure lawsuits to move forward quickly, and could also have implications for other cases against drug makers and medical device manufacturers as well.
Two bipartisan bills are also currently making their way through Congress that could close the preemption loophole, at least for makers of health care products.
One of these, Ariel Grace’s Law, named for an infant who was stillborn to a mother with an Essure device, would allow patients to sue manufacturers of Class III devices, regardless of whether or not it was approved under the FDA’s PMA process.
A companion bill, the Medical Device Guardians Act, would require individual physicians and clinics to file adverse event reports with the FDA, as hospitals and health care industry institutions are already required to do.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Weis Market Inc., a Mid-Atlantic food retailer based in Sunbury, Pennsylvania, has recalled its 48-ounce containers of Weis Quality Brownie Moose Tracks Ice Cream because the product may contain traces of egg, an allergen not declared on the ingredient statement label, according to the FDA.
Marlex Pharmaceuticals, Inc., of New Castle, Delaware, has announced a voluntary, consumer-level recall of one lot of Digoxin Tablets USP, 0125mg, as well as one lot of Digoxin Tablets USP, 0.25mg, because the labels of both products have been mixed up, according to the FDA.